Last10K.com

Uniqure N.V. (QURE) SEC Filing 8-K Material Event for the period ending Wednesday, October 24, 2018

Uniqure N.V.

CIK: 1590560 Ticker: QURE

View differences made from one to another to evaluate Uniqure N.V.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Uniqure N.V..

Continue

Assess how Uniqure N.V.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Uniqure N.V.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: QURE
CIK: 1590560
Form Type: 8-K Corporate News
Accession Number: 0001104659-18-063816
Submitted to the SEC: Thu Oct 25 2018 8:25:01 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Vote of Security Holders

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/qure/0001104659-18-063816.htm